642 related articles for article (PubMed ID: 33243535)
1. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
[TBL] [Abstract][Full Text] [Related]
2. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?
Marino R; Landau A; Lynch M; Callaway C; Suffoletto B
Addiction; 2019 Sep; 114(9):1575-1581. PubMed ID: 31013394
[TBL] [Abstract][Full Text] [Related]
3. Naloxone Administration in US Emergency Departments, 2000-2011.
Frank JW; Levy C; Calcaterra SL; Hoppe JA; Binswanger IA
J Med Toxicol; 2016 Jun; 12(2):148-56. PubMed ID: 26621354
[TBL] [Abstract][Full Text] [Related]
4. Rhode Island's Opioid Overdose Hospital Standards and Emergency Department Naloxone Distribution, Behavioral Counseling, and Referral to Treatment.
Samuels EA; Wentz A; McCormick M; McDonald JV; Marshall BDL; Friedman C; Koziol J; Alexander-Scott NE
Ann Emerg Med; 2021 Jul; 78(1):68-79. PubMed ID: 33865617
[TBL] [Abstract][Full Text] [Related]
5. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
[TBL] [Abstract][Full Text] [Related]
6. Addressing System and Clinician Barriers to Emergency Department-initiated Buprenorphine: An Evaluation of Post-intervention Physician Outcomes.
Mahal JJ; Bijur P; Sloma A; Starrels J; Lu T
West J Emerg Med; 2024 May; 25(3):303-311. PubMed ID: 38801034
[TBL] [Abstract][Full Text] [Related]
7. Impact of Emergency Department-Initiated Buprenorphine on Repeat Emergency Department Utilization.
Skains RM; Reynolds L; Carlisle N; Heath S; Covington W; Hornbuckle K; Walter L
West J Emerg Med; 2023 Nov; 24(6):1010-1017. PubMed ID: 38165181
[TBL] [Abstract][Full Text] [Related]
8. Naloxone and Buprenorphine Prescribing Following US Emergency Department Visits for Suspected Opioid Overdose: August 2019 to April 2021.
Chua KP; Dahlem CHY; Nguyen TD; Brummett CM; Conti RM; Bohnert AS; Dora-Laskey AD; Kocher KE
Ann Emerg Med; 2022 Mar; 79(3):225-236. PubMed ID: 34802772
[TBL] [Abstract][Full Text] [Related]
9. Naloxone prescriptions following emergency department encounters for opioid use disorder, overdose, or withdrawal.
Kilaru AS; Liu M; Gupta R; Perrone J; Delgado MK; Meisel ZF; Lowenstein M
Am J Emerg Med; 2021 Sep; 47():154-157. PubMed ID: 33812332
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
Rhee TG; Rosenheck RA
Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
[TBL] [Abstract][Full Text] [Related]
11. Continuation of outpatient buprenorphine therapy after dispensing Buprenorphine-Naloxone from the emergency department.
Krenz JR; Hayes BD; Wakeman SE; Martin A; Raja AS; White BA; Koehl JL
Clin Toxicol (Phila); 2022 Apr; 60(4):429-432. PubMed ID: 34409916
[TBL] [Abstract][Full Text] [Related]
12. Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.
D'Onofrio G; Edelman EJ; Hawk KF; Chawarski MC; Pantalon MV; Owens PH; Martel SH; Rothman R; Saheed M; Schwartz RP; Cowan E; Richardson L; Salsitz E; Lyons MS; Freiermuth C; Wilder C; Whiteside L; Tsui JI; Klein JW; Coupet E; O'Connor PG; Matthews AG; Murphy SM; Huntley K; Fiellin DA
JAMA Netw Open; 2023 Apr; 6(4):e235439. PubMed ID: 37017967
[TBL] [Abstract][Full Text] [Related]
13. Sustained Implementation of a Multicomponent Strategy to Increase Emergency Department-Initiated Interventions for Opioid Use Disorder.
Lowenstein M; Perrone J; Xiong RA; Snider CK; O'Donnell N; Hermann D; Rosin R; Dees J; McFadden R; Khatri U; Meisel ZF; Mitra N; Delgado MK
Ann Emerg Med; 2022 Mar; 79(3):237-248. PubMed ID: 34922776
[TBL] [Abstract][Full Text] [Related]
14. Race, ethnicity, and emergency department post-overdose care.
Reddy NG; Jacka B; Ziobrowski HN; Wilson T; Lawrence A; Beaudoin FL; Samuels EA
J Subst Abuse Treat; 2021 Dec; 131():108588. PubMed ID: 34384652
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated With Participation in an Emergency Department-Based Take-Home Naloxone Program for At-Risk Opioid Users.
Kestler A; Buxton J; Meckling G; Giesler A; Lee M; Fuller K; Quian H; Marks D; Scheuermeyer F
Ann Emerg Med; 2017 Mar; 69(3):340-346. PubMed ID: 27745764
[TBL] [Abstract][Full Text] [Related]
16. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019.
Griffith J; Yorlets RR; Chambers LC; Davis CS; Wentz A; Beaudoin FL; Baird J; Samuels EA
Am J Public Health; 2023 Apr; 113(4):372-377. PubMed ID: 36745856
[TBL] [Abstract][Full Text] [Related]
17. Implementing an overdose education and naloxone distribution program in a health system.
Devries J; Rafie S; Polston G
J Am Pharm Assoc (2003); 2017; 57(2S):S154-S160. PubMed ID: 28233681
[TBL] [Abstract][Full Text] [Related]
18. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.
Morgan JR; Schackman BR; Leff JA; Linas BP; Walley AY
J Subst Abuse Treat; 2018 Feb; 85():90-96. PubMed ID: 28733097
[TBL] [Abstract][Full Text] [Related]
19. Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose.
Weiner SG; Carroll AD; Brisbon NM; Rodriguez CP; Covahey C; Stringfellow EJ; DiGennaro C; Jalali MS; Wakeman SE
J Subst Abuse Treat; 2022 Aug; 139():108785. PubMed ID: 35537918
[TBL] [Abstract][Full Text] [Related]
20. Opioid education and nasal naloxone rescue kits in the emergency department.
Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
